Gregory Bernstein
Member @ Rising Tide Collective
Stockholm, Sweden
Gregory Bernstein is a Series A investor at Rising Tide Collective in Stockholm focused on Biotechnology and Manufacturing. Gregory Bernstein is the Gregory Bernstein Venture Lead at EQT Ventures . He attended Georgetown University.
- Total investments:
- 7
- Last investment:
- Lead investor:
- 86%
Last updated:
For AI agents: llms.txt
Industries Gregory Bernstein invests in
Stages Gregory Bernstein invests in
Countries Gregory Bernstein invests in
Round sizes
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Round size
- Series A
- $15M–$60M
- Venture - Series Unknown
- $13M–$118M
Investment Focus
Industry
- Biotechnology 2 (29%)
- Manufacturing 2 (29%)
- Industrial Manufacturing 2 (29%)
- AgTech 1 (14%)
- Battery 1 (14%)
Stage
- Series A 3 (43%)
- Venture - Series Unknown 2 (29%)
- Seed 1 (14%)
Country
- Germany 2 (29%)
- France 1 (14%)
- United States 1 (14%)
- United Kingdom 1 (14%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Insempra
|
Origin.Bio creates synthetic microorganisms that can make many of the same ingredients as traditional chemical industrialization processes today, but with significantly fewer energy requirements and waste produced while eradicating the need for petrochemicals.The company drives the convergence of engineering with biology, using DNA as theprogramming language. Rather than editing genetic material only in or out of DNA, engineers can hack entirely new organisms that have never existed — all powered by computing, automation, and artificial intelligence (AI)/machine-learning while leveraging millions of years of evolution. Operating at an atomic level, the company farms organisms with microscopic precision and integrates them into existing original equipment manufacturer (OEM) manufacturing processes. This asset-light approach enables Origin.Bio to generate sustainable materials at speed in a cost-effective way, without compromising on performance. | $20M / Series A / May 07, 2024 | |
Harbinger
|
Founded by veterans of Canoo and Faraday Future, Harbinger is an automotive company that develops EV platforms optimized for medium-duty trucks and delivery vans. | $60M / Series A / Sep 20, 2023 | |
Legendairy Foods
|
Formo is Europe’s first cellular agriculture company developing animal-free dairy products using real, nature-identical milk proteins derived from precision fermentation. | $44.6M / Series A / Sep 13, 2021 | |
Verkor
|
Verkor is a battery cell manufacturer whose goal is to increase the production of low-carbon batteries to fulfill the growing demand for electric vehicles. The company focuses on the development of low-carbon batteries with a carbon footprint that is many times smaller than standard batteries. This reduces the logistics footprint, includingemissions, and provides businesses with batteries that are very inexpensive and use carbon-free electricity. | $117.9M / Venture - Series Unknown / Jul 07, 2021 | |
|
Insempra
|
Origin.Bio creates synthetic microorganisms that can make many of the same ingredients as traditional chemical industrialization processes today, but with significantly fewer energy requirements and waste produced while eradicating the need for petrochemicals.The company drives the convergence of engineering with biology, using DNA as theprogramming language. Rather than editing genetic material only in or out of DNA, engineers can hack entirely new organisms that have never existed — all powered by computing, automation, and artificial intelligence (AI)/machine-learning while leveraging millions of years of evolution. Operating at an atomic level, the company farms organisms with microscopic precision and integrates them into existing original equipment manufacturer (OEM) manufacturing processes. This asset-light approach enables Origin.Bio to generate sustainable materials at speed in a cost-effective way, without compromising on performance. | $15M / Series A / May 25, 2021 | |
|
Insempra
|
Origin.Bio creates synthetic microorganisms that can make many of the same ingredients as traditional chemical industrialization processes today, but with significantly fewer energy requirements and waste produced while eradicating the need for petrochemicals.The company drives the convergence of engineering with biology, using DNA as theprogramming language. Rather than editing genetic material only in or out of DNA, engineers can hack entirely new organisms that have never existed — all powered by computing, automation, and artificial intelligence (AI)/machine-learning while leveraging millions of years of evolution. Operating at an atomic level, the company farms organisms with microscopic precision and integrates them into existing original equipment manufacturer (OEM) manufacturing processes. This asset-light approach enables Origin.Bio to generate sustainable materials at speed in a cost-effective way, without compromising on performance. | $15M / Seed / May 25, 2021 | |
Biomicrogels Group
|
Biomicrogels Group is the developer and patent holder for biomicrogels - a unique substance produced from agricultural waste such as sugar beet, apple, sunflower pomace - capable of addressing the global environmental and climate change problems.The company's biomicrogel-based solutions add value in produced water treatment, cutting fluidseparation, vegetable oil extraction, cleaning of oil spills at sea and on land.We also manufacture a range of environmentally friendly household cleaning products under own brand, WONDERLAB. | $13M / Venture - Series Unknown / Apr 20, 2021 |
Co-Investors
About Rising Tide Collective
Rising Tide Collective Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Gregory Bernstein
Member
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Gregory Bernstein invest in?
Gregory Bernstein invests primarily in Biotechnology, Manufacturing and Industrial Manufacturing startups, most often at Series A and Venture - Series Unknown stage. Most of the 7 investments tracked by Shizune back companies in Germany. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Gregory Bernstein's check size?
Gregory Bernstein typically joins rounds of $15M–$60M at Series A and $13M–$118M at Venture - Series Unknown. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Gregory Bernstein participates in.
How do I contact Gregory Bernstein?
Public channels for Gregory Bernstein include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Gregory Bernstein last invest?
The most recent investment recorded for Gregory Bernstein closed in May 2024. Shizune tracks 7 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
